Hints and tips:
...Lars Fruergaard Jorgensen, chief executive of Novo Nordisk, the world’s biggest insulin maker, suggests this is the missing piece for all drugmakers....
...For now, larger western pharmaceutical companies remain reluctant, with little in their late-stage pipelines except for Novo Nordisk of Denmark, the specialist diabetes company....
...Jesper Kløve, senior vice-president and head of device research and development at Novo Nordisk, the Danish pharmaceutical group, which employs five full-time designers and uses several outside consultancies...
...Some – such as Novo Nordisk and Roche – remain focused on a single global price for their drugs to maximise returns and reduce the risk of “leakage” from lower to higher priced markets....
...Danish drugmaker Novo Nordisk rose 2 per cent to DKr356.10....
International Edition